Skip to content
10-K

Annual Report

CASTLE BIOSCIENCES, INC. CSTL

0001447362-25-000031

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 20, 2025 28.51M sh
Long Term Debt FY 2024 · Dec 31, 2023 $0
Cash And Equivalents FY 2024 · Dec 31, 2023 $98.84M
Current Liabilities FY 2024 · Dec 31, 2023 $47.67M
Total Liabilities FY 2024 · Dec 31, 2023 $62.07M
Current Assets FY 2024 · Dec 31, 2023 $295.64M
Total Assets FY 2024 · Dec 31, 2023 $453.34M
Shares Diluted FY 2024 · Dec 31, 2022 26.05M sh
Capex FY 2024 · Dec 31, 2022 $5.63M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$41.66M
Eps Diluted FY 2024 · Dec 31, 2022 −$2.58
Eps Basic FY 2024 · Dec 31, 2022 −$2.58
Sga Expense FY 2024 · Dec 31, 2022 $143M
Rd Expense FY 2024 · Dec 31, 2022 $44.9M
Net Income FY 2024 · Dec 31, 2022 −$67.14M
Operating Income FY 2024 · Dec 31, 2022 −$72.86M
Cost Of Revenue FY 2024 · Dec 31, 2022 $32.01M
Revenue FY 2024 · Dec 31, 2022 $137.04M
Stockholders Equity FY 2024 · Dec 31, 2021 $411.74M